Menin is a tumor suppressor protein mutated in patients with multiple endocrine neoplasia type 1. We show that menin is essential for canonical Wnt/Bcatenin signaling in cultured rodent islet tumor cells.
Introduction
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease characterized by the development of parathyroid hyperplasia, pancreatic islet cell tumors, and anterior pituitary endocrine tumors (1) . Besides these classic tumors, several other endocrine and nonendocrine tumors may develop, including lipomas, dermatofibromas, collagenomas, ependymomas, meningiomas, schwannomas, carcinoids, adrenal cortical tumors, and thyroid tumors. The MEN1 gene is highly conserved and encodes for a 67-kDa nuclear protein, called menin, which has been implicated in DNA metabolism and transcription regulation (2) . MEN1 patients have truncation mutations and missense mutations that are predicted to inactivate menin function consistent with a tumor suppressor protein (3) . Homozygous knockout mice (Men1 À/À ) die in utero (E11.5-13.5) with multiple developmental defects, suggesting that menin that has an essential role in early development (4) . Similar to MEN1 patients, heterozygous knockout mice (Men1 À/+ ) develop normally, but the adult mice eventually grow endocrine tumors (5) .
To determine how the loss of menin promotes endocrine tumor development, most investigations have focused on the role of menin in transcription regulation. Menin interacts with several transcription factors including members of the activator protein-1 (JunD), transforming growth factor-h/bone morphogenetic protein (RUNX2, SMAD1, SMAD3, and SMAD5), and nuclear factor-nB (p65, p50, and p52) signal transduction pathways (6) (7) (8) (9) (10) (11) . More recently, menin was identified in MLL and MLL2 histone methyltransferase complexes and found essential for the histone methyltransferase activity (12) (13) (14) (15) (16) .
Pancreas development, in particular islets, is mediated by expression of a specific program of growth factors including the Wnt proteins (17) (18) (19) (20) (21) (22) (23) (24) . In general, Wnt proteins regulate development through actions on cell proliferation, differentiation, cell fate decisions, apoptosis, axial polarity, axonal guidance, and adhesion (25) . In the canonical Wnt pathway, the extracellular Wnt ligand (20 different genes in mammalian cells) binds the cell surface receptor frizzled (10 FZD genes in mammalian cells) and the coreceptor LRP5/6 (low density lipoprotein receptor -related proteins 5 and 6). This initiates a cascade of intracellular mediators that results in h-catenin stabilization and subsequent h-catenin nuclear localization to regulate target gene transcription (26) . In the absence of Wnt ligand, h-catenin is phosphorylated in a cytoplasmic complex with casein kinase 1, glycogen synthase kinase 3h (GSK3h), axin 1, and the tumor suppressor adenomatous polyposis coli. Phosphorylated h-catenin is ubiquitylated and targeted for degradation by the proteasome. Wnt binds the Fzd receptor and stops phosphorylation of h-catenin. The hypophosphorylated h-catenin translocates to the nucleus where it associates with the T-cell -specific transcription factor/lymphoid enhancer binding factor 1 (TCF/LEF) family transcription factors and regulates Wnt responsive genes expression.
Components of the Wnt pathway regulate pancreas development, although the mechanism is not fully understood. Numerous members of the Wnt pathway are expressed during the development of the mouse pancreas and in the adult organ (27) . In particular, activated (dephosphorylated) h-catenin and the parahox protein Pdx-1, which signals pancreas lineage development, are both expressed in the pancreas epithelium during development (20) . Pdx-1 promoter directing Wnt misexpression in a transgenic mouse model results in pancreas agenesis (28) . A h-catenin conditional knockout mouse, however, loses normal pancreatic acinar tissue development, but islet development is preserved (22) . Whereas it is clear that Wnt signaling and h-catenin are important for pancreas development, its role in pancreatic endocrine tumor development is unknown.
Based on the role of menin in multiple cell signaling pathways and the broad role of Wnt signaling in tumor development, we hypothesized that menin may be important for Wnt/h-catenin signaling in endocrine tumors. In this report, we investigate the role of menin in Wnt/h-catenin signaling in a mouse islet cell line. These data suggest menin is important for regulation of Wnt signaling in the endocrine pancreas through a mechanism that involves histone H3K4 trimethylation.
Results

Expression of Endogenous b-Catenin, TCF3, and TCF4 in Endocrine and Nonendocrine Cell Lines and the Effect of Menin Overexpression
Canonical Wnt pathway protein expression in endocrine tumor cell lines has not been previously reported. Therefore, we first determined the expression of activated (dephosphorylated) h-catenin in selected islet tumor endocrine (TGP-61 and InR1G9) and nonendocrine cell lines (HEK 293T). Endogenous h-catenin protein was expressed in all three cell lines (Fig. 1A) . The amount of activated h-catenin protein expression, however, was variable, with highest expression in the mouse islet tumor cell line TGP-61 (29) , slightly less in human embryonic kidney cells HEK 293T (30), and barely detectable in the hamster islet cell line InR1G9 (31) . We then examined the expression of two of the TCF/LEF family members. TCF3 (also called TCF7L1) and TCF4 (also called TCF7L2) were both highly expressed in TGP-61 cells, but TCF4 was predominantly expressed in both HEK 293T and InR1G9 cells. Whereas the expression patterns of TCF4 and TCF3 differ in these cell lines, these proteins are functionally similar (25) . Overexpression of menin did not affect the expression of TCF4, TCF3, or activated (dephosphorylated) h-catenin in any of the cell lines studied. In cells expressing fluorescent epitope -tagged h-catenin, TCF3, and TCF4, menin overexpression did not affect the nuclear localization of these proteins (Fig. 1B) . These data suggest that proteins important for canonical Wnt signaling are expressed in these cell lines, in particular the mouse islet tumor cell line TGP-61, and their expression is not altered by exogenous menin. Specifically, the amount of activated (dephosphorylated) h-catenin is not altered by menin overexpression.
Menin Is Essential for b-Catenin Activation of a TCF Responsive Reporter
To determine whether menin is involved with Wnt/h-catenin signaling, we studied mouse TGP-61 islet tumor cells transfected with a TCF responsive luciferase reporter vector (Super8XTOPflash, M50) containing eight TCF/LEF binding sites or a control vector (Super8XFOPflash, M51) that has mutant TCF/LEF binding sites (32) . As expected, overexpression of either wild-type h-catenin or the constitutively activated phosphorylation mutant h-catenin (S37A; ref. 33) increased TCF reporter gene assay activity ( Fig. 2A) . Menin alone did not activate the reporter gene, but cotransfection of menin and either h-catenin or activated h-catenin (S37A) strongly stimulated the reporter gene activity severalfold above that seen with either h-catenin or h-catenin (S37A) alone. One possible explanation for the increased reporter activity with menin overexpression could be altered h-catenin expression, but Western blot analysis shows similar expression of h-catenin when menin is co-overexpressed with h-catenin or h-catenin (S37A; Fig. 2A, right) . To determine whether menin was affecting the reporter promoter through a mechanism not involving the TCF response elements, similar experiments were done comparing the response of the control reporter gene, Super8XFOPflash (plasmid M51 labeled ''F'' in Fig. 2B ), which has mutant TCF binding sites, with the response from the nonmutated reporter Super8XTOPflash (plasmid M50 labeled ''T'' in Fig. 2B ). Menin and h-catenin did not activate the negative control reporter gene Super8XFOPflash that has mutant TCF binding sites (Fig. 2B) . Expression of the overexpressed proteins is shown in Fig. 2B (right) , indicating that the transfections of multiple plasmids did not significantly interfere with each other. We then wondered whether Wnt/hcatenin signaling was dependent on menin function. We tested this hypothesis by decreasing menin expression with transfection of mouse specific menin-optimized siRNA (TGP61 is a mouse derived cell line). Several different menin siRNAs were tested (see Materials and Methods) with the most effective siRNA chosen for subsequent experiments. Decreased menin expression significantly inhibited reporter gene activity in response to transfected h-catenin (label ''M'' in Fig. 2C ) compared with control siRNA (label ''C'' in Fig. 2C ). Western blot analysis confirmed that menin protein expression was reduced by the siRNA transfection (Fig. 2C, right) . Similar studies in human embryonic kidney (HEK 293T) cells showed that menin more modestly augmented reporter gene activity in the presence of h-catenin (data not shown).
We then wondered whether disease-associated menin mutations would lose the ability to augment Wnt/h-catenin -mediated signaling. All of the disease-associated menin missense and COOH-terminal deletion mutants studied (mutants illustrated in Fig. 3A) lost the ability to stimulate h-catenin -mediated reporter gene activity ( Fig. 3B and C) consistent with a role for menin in canonical Wnt/h-catenin -mediated signaling. The menin truncation mutants (meninDB-E) had lower expression compared with wild-type menin (Fig. 3C, right) . To adjust for this effect, we transfected more plasmid DNA and increased expression of the truncated proteins, but this further decreased reporter activity as if truncated menin was acting in a dominant negative fashion (data not shown). Overexpression of the missense mutants was comparable to wild-type menin overexpression (Fig. 3C, right) . Like the menin deletion mutants, there was loss of TCF gene assay reporter activity augmentation with these menin missense mutants compared with overexpression of wild-type menin (Fig. 3C, left) .
The COOH Terminus of Menin Interacts with b-Catenin, TCF3, and Weakly with TCF4
Because Wnt signaling is mediated by h-catenin binding members of the TCF/LEF transcription factor family at target gene promoters (34), we wondered whether menin interacted with either h-catenin, TCF3, or TCF4. Because exogenously overexpressed proteins may aggregate and produce artificial interactions detected by immunoprecipitation, endogenous menin/h-catenin interactions were investigated (Fig. 4A) . HEK 293T cells were treated with vehicle or a GSK3h inhibitor IX (BIO) to activate the canonical Wnt signaling cascade, and endogenous menin/h-catenin coimmunoprecipitation was done. Treatment with the GSK3h inhibitor increased expression of activated h-catenin (see Fig. 4A , bottom). Immunoprecipitation with anti -activated h-catenin that recognizes h-catenin dephosphorylated on Ser 37 or Thr 41 confirmed that endogenous menin coimmunoprecipitated with activated h-catenin with GSK3h inhibitor treatment. This does not prove that h-catenin dephosphorylation is necessary for the menin interaction, but more likely that nuclear localization increases expression of endogenous h-catenin, activated (dephospho)h-catenin, and TCF3/4 in various cell lines transfected with either empty vector or pCMV-SPORT-menin (designated À and +, respectively). Forty-eight hours after transient transfection with either control vector or a menin-expressing plasmid (pCMV-Sport-menin), plated cells (HEK 293T, TGP-61, and InR1G9) were harvested and the protein lysate was immunoblotted and probed with antibodies to h-catenin, activated h-catenin (recognize h-catenin dephosphorylated on Ser 37 or Thr 41 ), and TCF3/4. Anti-menin antibody was used to confirm overexpression of menin in the pCMV-Sport-menin -transfected cells, and anti -h-tubulin was used to show equal protein loading. For each protein detected such as menin, all images from different cell lines were from the same Western blot and exposure, but the images were separated for publication purposes.
B. TGP-61 mouse pancreas islet tumor cells expressing fluorescent epitope -tagged expression constructs show colocalization of menin with h-catenin and TCF3/4. ECFP images are pseudocolored red to distinguish these images from Hoechst dye nuclear staining. ECFP-h-catenin is predominantly nuclear due to overwhelming the proteasome degradation pathway by high levels of ECFP-h-catenin protein expression, but some cytoplasmic protein is still visualized. All images were obtained with 63Â objective. the likelihood of interaction because endogenous and overexpressed menin is largely located within the nucleus. Similar interaction between endogenous menin and h-catenin was shown in TGP61 cells by coimmunoprecipitation (data not shown).
Based on these data, menin could either directly complex with h-catenin or indirectly interact as part of a large complex. We tested this hypothesis by performing in vitro pull-down assays. For these interaction experiments, an NH 2 -terminal deletion FIGURE 3. Mutant menin loses its ability to promote Wnt/h-catenin signaling. All experiments were done with triplicate (n = 3) transfections, with the results graphed as the mean F SD. In all of the experiments, the amount of plasmid DNA transfected was kept constant by adding empty vector DNA as needed for each sample. All samples were transfected with the control vector pRL-hTK (Renilla luciferase) to adjust the results for transfection efficiency. A.
Diagram illustrates human MEN1 gene structure, disease-associated missense mutants, COOH-terminal deletion mutants, and NH 2 -terminal deletion mutants used in this article. Exons are numbered 1 to 10. Exon 10 is shortened for illustration purposes. Disease-associated menin missense mutants are designated above the gene structure. The COOH-terminal menin deletion mutants are designated by the amino acid that is mutated to a stop codon within the menin protein. The NH 2 -terminal deletion menin mutants show the amino acid residues expressed by the expression vector. B. Menin COOH-terminal deletion mutants lose the ability to promote TCF luciferase gene assay reporter activity in TGP61 cells. TGP-61 cells were transfected with the reporter vector M50 and cotransfected with pSport-h-catenin with or without pSport-menin in the presence of different menin COOH-terminal deletion mutants (meninDB-E). TCF reporter gene assay activity was measured by the Dual Luciferase Assay (Promega) and the results of the firefly luciferase/Renilla luciferase ratio are graphed for each sample set. Western blot analysis (B, right ) shows decreased expression of the transfected menin deletion mutants compared with overexpressed wild-type menin. Increasing the deletion mutant menin plasmid expression by increasing the amount of transfected plasmid (meninDB-E) further decreased reporter activity (data not shown). Protein loading was confirmed by h-tubulin expression. C. Menin missense point mutants lose the ability to promote TCF gene assay reporter activity in TGP61. TGP-61 cells were transfected with the reporter vector M50 and cotransfected with pSport-h-catenin with or without pSport-menin or missense menin mutants (P12L, L22R, H139Y, A160P, A176P, and L286P). Right, corresponding Western blot for the transfected proteins. Protein loading was confirmed by h-tubulin expression. mutant, meninD5s (contains amino acids 477-610), was expressed as a glutathione S-transferase (GST) fusion protein in bacteria, purified by immobilized glutathione gel, and incubated with in vitro transcribed-translated (TnT) h-catenin, TCF4, and TCF3 (Fig. 4B) . The proteins bound to the NH 2 -terminal deletion mutant and analyzed by Western blot analysis revealed specific pull-down of h-catenin, TCF3, and TCF4 by GST-meninD5s. These proteins were not seen with the GST control protein. Menin, therefore, directly interacts with h-catenin, TCF3, and TCF4.
To define the menin interaction region, menin and h-catenin were coexpressed in HEK 293T cells and coimmunoprecipitated (Fig. 5A ). Full-length menin specifically coimmunoprecipitated with h-catenin. To determine the region of the menin protein that binds to h-catenin, HEK 293T cells were cotransfected with different menin deletion mutants (see diagram Fig. 3A) . The coimmunoprecipitation studied showed that h-catenin binds to the COOH-terminal region of menin (Fig. 5A) . COOH-terminal menin truncation mutants (meninDB-D), on the other hand, largely lost the ability to interact with h-catenin (Fig. 5B) . The longest of these COOH-terminal deletion mutants, meninDE, weakly interacted with h-catenin. The majority of naturally occurring disease-associated truncation mutations, therefore, would be predicted to lose the ability to interact with h-catenin. We then wondered whether menin interacted with other members of the h-catenin transcription complex and showed that menin could bind TCF3 or weakly with TCF4 either directly or as part of a larger complex by coimmunoprecipitation in HEK 293T cells (Fig. 5C ).
Menin Regulates Wnt Downstream Target Axin2 Gene Expression
Because menin significantly increased TCF reporter gene activity in the presence of activated h-catenin, we wondered whether endogenous gene expression was likewise affected in TGP-61 cells. To identify a target gene modulated by Wnt/h-catenin signaling in TGP-61 cells, we studied the mRNA expression of several known downstream target genes: c-MYC, NKX2-2, Taspase, PDX1, LEF, MET, CDX1, HNF3B, HDAC9, LMX1, and AXIN2 (35 COOH terminus interacts with h-catenin, TCF3, and TCF4 in vitro as shown by GST pull-down assay. GST-tagged meninD5s (contains menin COOH terminus) was expressed in bacteria and immobilized on glutathione-coated agarose beads. In vitro transcribed and translated (TnT System from Promega) and biotin-labeled (Transcend from Promega) h-catenin, TCF3, and TCF4 were used for pull-down assay and analyzed by Western blotting. Input represents 10% of the TnT product to control for the amount of protein used to show interaction. Biotinylated TnT products were detected by the Transcend Non-Radioactive Translation Detection System from Promega (labeled TNT in figure).
expression constructs for menin and h-catenin (S37A) showed increased Axin2 gene expression in response to h-catenin in both TGP-61 and HEK 293T cells (Fig. 6A) . There was no effect on b-actin gene (loading control) expression. Similarly, Axin2 protein expression was increased in response to increased h-catenin and menin/h-catenin expression (Fig. 6B) . Expression of other Wnt regulated genes tested was not affected by Wnt signaling in these particular cell lines. This is not surprising because the Wnt signaling response is likely tissue specific and the particular target genes for endocrine cell types are unknown. Based on the reporter gene assay data, we hypothesized that decreased menin expression would block h-catenininduced Axin2 transcription. Indeed, h-catenin-induced Axin2 gene transcription was repressed by siRNA knockdown of menin expression in TGP-61 cells (Fig. 6C and D) . Supplementary Fig. S1 ). These data suggest that at least one endogenous canonical Wnt/h-catenin signaling target gene (Axin2) is dependent on menin expression.
Menin Is
Axin2 gene expression is regulated by the Wnt/h-catenin signaling pathway in TGP-61 mouse islet tumor cells and menin is essential for this signaling (see above), but the exact molecular role for menin is unknown. Because menin is known to bind MLL histone methyltransferase complexes (13, 15) , we hypothesized that menin could be involved in histone H3K4 trimethylation at the Axin2 gene promoter in response to Wnt/ h-catenin signaling. Using the chromatin immunoprecipitation assay with an antibody to trimethylated histone 3 lysine 4 (anti-H3K4) and DNA amplification by PCR for the proximal Axin2 promoter (genomic regions designated T2 and T3; ref. 36 ; Fig. 7A ), we showed increased histone H3 K4 trimethylation in the h-catenin (S37A) -transfected TGP-61 islet tumor cells compared with empty vector -transfected cells (Fig. 7B) . Histone H3K4 trimethylation was further increased when the active h-catenin (S37A) was cotransfected with the menin expression vector (Fig. 7B) . (Fig. 7C) . Hence, menin is directly or indirectly essential for Axin2 gene promoter histone H3K4 trimethylation in response to Wnt/h-catenin signaling.
Increased Wnt/h-catenin signaling decreases TGP61 islet tumor cell proliferation in vitro. Based on the above studies, we hypothesized that increased Wnt signaling could inhibit islet cell proliferation because loss of menin function is thought to increase endocrine tumor cell proliferation. Indeed, TGP61 islet tumor cells transfected with menin siRNA show increased cell proliferation compared with control transfected cells (Supplementary Fig. S2 ). To determine whether Wnt signaling affects TGP16 rodent islet tumor cell proliferation, TGP61 cells were treated with a GSK3h inhibitor (BIO, Calbiochem) that increases Wnt pathway signaling by decreasing h-catenin proteasome -mediated degradation (Fig. 8A ). Western blot analysis shows that GSK3h inhibitor treatment increased activated h-catenin expression compared with vehicle-treated cells. In addition, cell counting at 0, 24, 48, and 72 hours showed decreased cell proliferation compared with vehicletreated cells (Fig. 8B) . Flow cytometry analysis suggests that this is due to an increase in G 2 -M phase arrested cells (Supplementary Fig. S3 ).
Discussion
In this study, we show that menin is essential for Wnt/hcatenin signaling in a mouse islet tumor cell line. The molecular mechanism involves a direct interaction between h-catenin and the COOH terminus of menin at the target gene promoter (Axin2 in this study) and resultant histone H3K4 trimethylation. Menin COOH-terminal truncation mutants lose their ability to interact with h-catenin and their ability to increase TCF gene reporter activity, which is consistent with a requirement for inactivation of Wnt signaling during islet tumor development. Although these studies show that histone H3K4 trimethylation B. Overexpression of menin increases Wnt/h-catenin signaling -associated Axin2 gene promoter H3K4 trimethylation. Top, agarose gels with PCR products from the chromatin immunoprecipitation assay. TGP-61 cells were transfected with empty expression vector (UV ), active h-catenin (S37A ) expression vector, or h-catenin (S37A)/menin expression vectors as shown. Forty-eight hours later, the chromatin immunoprecipitation assay was done with a trimethyl specific anti-H3K4 antibody. The T2/T3 promoter region was PCR amplified as depicted in the gene diagram above. Bottom, input DNA loading for the PCR. is affected at the Axin2 promoter, we do not know whether this is a direct or indirect effect.
C. Menin expression knockdown abrogates
Because menin is inactivated in MEN1-associated endocrine tumors, we hypothesize that canonical Wnt signaling could be diminished in these tumors. This contradicts the typical role of Wnt activation in several malignancies such as colon cancer (25, 37, 38) and recent data suggesting that Wnt signaling is important for h-cell proliferation (39, 40) . Most tumors with Wnt signaling abnormalities reported reveal activation of this pathway, but a few tumors such as salivary gland tumors have inactivation of the Wnt pathway (41) . Menin inactivation could contribute to tumorigenesis by disabling the canonical Wnt pathway. Indeed, activation of Wnt/h-catenin signaling in TGP61 cells resulted in decreased cell proliferation. This hypothesis is supported by mouse models showing that Wnt/h-catenin inactivation results in the loss of pancreas acinar cell development, but promotes or at least preserves pancreas islet development (22) . None of these transgenic models of Wnt signaling/h-catenin signaling develop endocrine tumors, suggesting that Wnt signaling may not be critical for MEN1-associated tumor development. A Men1 knockout mouse model, however, showed that hcatenin is predominantly cytoplasmic, rather than nuclear, in the islet tumors (42).
Men1 homozygous knockout mice, however, do have craniofacial bone development abnormalities, and menin has been proposed to have a direct role in bone development (reviewed in ref. 43 ). Because Wnt/h-catenin has also been implicated in bone development, it is possible that menin is critical for proper osteoblast differentiation, in part, through Wnt signaling and h-catenin/menin transcriptional activation of RUNX2, the master regulator of bone formation (see review in ref. 44 ).
In the absence of Wnt signaling, TCF/LEF transcription factors form a complex with Groucho/Grg/transducin-like enhancer-of-split proteins and thereby function as a transcription repressor (reviewed in ref. 26) . With Wnt signaling, hcatenin displaces Groucho from the TCF/LEF complex and thereby activates transcription. The mechanism for transcription activation is hypothesized to involve interaction with coactivators such as the histone acetylase, cyclic AMP-responsive element binding protein -binding protein, and brahma-related gene 1, which is a component of the SWI/SNF family of the ATP-dependent chromatin remodeling complexes. Histone methylation is also thought to be involved (45) . Because menin interacts with both h-catenin and the histone methyltransferase complex, we hypothesize that menin is important for recruitment of MLL histone methyltransferase to the h-catenin/TCF activator complex at the gene promoter.
Interestingly, parafibromin, which is the tumor suppressor protein mutated in hyperparathyroidism-jaw tumor syndrome 2, also binds h-catenin and regulates Wnt target gene transcription through a mechanism thought to involve the PAF1 complex (Paf1, Cdc73, Leo1, Ctr9, and Rtf1; ref. 46) . Hence, MEN1 and hyperparathyroidism-jaw tumor syndrome 2 may share a similar signaling pathway mechanism involving histone methylation and Wnt signaling. We found that Axin2 expression is regulated in our mouse islet tumor cell culture model for studying menin function. This is not surprising because Axin2 is considered a possible universal Wnt/h-catenin target, perhaps as part of autoregulation of this pathway (25) . It will be important to identify islet-specific targets, if they exist, and further to understand the role of Wnt signaling in islet cell biology as well as tumor development.
Materials and Methods
Reagents and Cell Lines
Hamster islet tumor cells InR1G9 (kind gift from Dr. Craig Smith) and human embryonic kidney cells (HEK 293T from American Type Culture Collection) were cultivated in DMEM (Mediatech, Inc.) supplemented with 10% fetal bovine serum (Omega, Inc.), 2 mmol/L L-glutamine, 100 units/mL penicillin, and 100 Ag/mL streptomycin (Omega). Mouse islet tumor cells (TGP-61 from American Type Culture Collection) were cultivated in 50% DMEM/50% F12K medium (Mediatech) supplemented with 10% fetal bovine serum and L-glutamine/ penicillin/streptomycin. The rat monoclonal anti-hemagglutinin antibody (12CA5) was purchased from Roche Applied Science. The monoclonal anti-FLAG (M2) antibody was purchased from Sigma-Aldrich. The rabbit polyclonal anti-menin antibody (BL342) and the goat anti-GST antibody were purchased from Bethyl Laboratories. The mouse monoclonal anti-His G antibody was purchased from Invitrogen Corp. The antimouse Axin2 antibody (ab32197) was purchased from Abcam. The TCF/LEF reporter plasmid Super8XTOPflash (M50) and its control mutant plasmid Super8XFOPflash (M51) were kind gifts from Dr. Randall T. Moon. The human MEN1 full-length wildtype and missense mutation expression constructs in the vector pCMV-SPORT were a kind gift from Dr. Sunita Agarwal.
siRNA and Transfection siRNAs were purchased from Dharmacon RNA Technologies. Mouse Men1 siRNA SMARTpools were optimized to find the best suppressor of menin expression (optimum mouse Men1 siRNA sequence: GCUAAGACCUACUACCAGGUU) determined by reverse transcription-PCR (RT-PCR) and Western blot analysis. Non-Specific Control-V siRNA was used as a siRNA control. Cells were transfected using Oligofectamine (Invitrogen) transfection reagent. For experiments requiring inhibition of Wnt signaling, the cells were mock treated with vehicle or treated by GSK3h inhibitor IX (Calbiochem) 5 Amol/L for 1 h before harvesting the cells. Reduction of mouse Men1 mRNA expression was confirmed by RT-PCR and mouse menin protein expression was confirmed by Western blot analysis.
Construction of Expression Plasmids
Recombinant expression plasmids were constructed as described (47) . Briefly, a full-length MEN1 cDNA was isolated by screening a human PBL E phage cDNA library (Clontech Laboratories, Inc.), probed with a random primed radiolabeled probe (Boehringer Mannheim), and PCR amplified (PCR Advantage, Clontech Laboratories) using the 500-bp genomic fragment from the first exon of human menin. The open reading frame of this full-length E phage cDNA clone (internal lab designated clone E$-menin-1.2.3) was high-fidelity PCR amplified (PCR Advantage) with primers 5 ¶-gaattcATGGGGCTGAAGGCC (small case: EcoRI restriction site) and 5 ¶-TCAGAGGCCTTTGCG, and then TA cloned into vector pCR2.1 (Invitrogen). Fidelity of the PCR DNA amplification and cloning was confirmed by fully sequencing the entire pCR2.1-menin (internal lab clone E4.1) insert in both directions. The pcDNA3.1/HisC-menin construct was created by subcloning the MEN1 open reading frame fragment from pCR2.1-menin into the EcoRI site of the pcDNA3.1/HisC expression vector (Invitrogen). An expression construct for hemagglutinin epitope -tagged menin (pcDNA3.1-HA-menin) was created by PCR DNA amplification of full-length MEN1 open reading frame (pCR2.1-menin) using primers 5 ¶-gaattcGCCATGTACCCATACGATGTTCCAGATTACGCT-TA C C C ATA C G AT G T T C C A G AT TA C G C T G G G C T-GAAGGCCGCC (2xHA epitope underlined; EcoRI site shown in small case) and 5 ¶-CCggatccTTCAGAGGCCTTTGCG (small case: BamHI site not used for this construct). The 2xHA-menin PCR fragment was TA cloned back into pCR2.1 (pCR2.1-HA-menin). The Eco RI-Eco RI fragment from pCR2.1-HA-menin was subcloned into the EcoRI site of pcDNA3.1 (Invitrogen).
Hemagglutinin epitope -tagged menin COOH-terminal deletion mutants, pcDNA3.1-HA-meninDB (delete amino acids 263-610), meninDC (delete amino acids 341-610), meninDD (delete amino acids 460-610), and meninDE (delete amino acids 527-610), were generated from pCR2.1-HA-menin (see above) by site-directed mutagenesis (48) and subcloning into the expression vector pcDNA3.1.
The menin NH 2 -terminal deletion mutants pcDNA3.1/HisCmeninD2 (delete amino acids , meninD3 (delete amino acids 1-276), meninD4 (delete amino acids 1-382), and meninD5 (delete amino acids 1-443) were generated from pCR2.1-menin (see above) by subcloning respectively the blunted HincII-BamHI fragment, blunted BstEII-BamHI fragment, blunted KpnI-BamHI fragment, blunted BstXI-BamHI fragment, and blunted AvrII-BamHI fragment into pcDNA3.1/ HisC. The pcDNA3.1HisB-meninD6 (delete amino acids 1-526) mutant was created by PCR DNA amplification using the primer 5 ¶-CgaattcCCGAGGCCCTGAAGG (small case: EcoRI site) and vector BGH reverse primer 5 ¶-TAGAAGGCACAGTC-GAGG, and then the PCR fragment was cloned into the pcDNA3.1HisB vector (Invitrogen).
The GST-menin NH 2 -terminal deletion mutant pGEX4T2-meninD5s (delete amino acids 1-476) was created by subcloning the SmaI-NotI fragment of pcDNA3.1-menin into the bacteria expression vector pGEX4T2 (GE Healthcare BioSciences Corp.) SalI-blunted/NotI restriction sites.
Two menin missense mutant expression constructs, pCMV-SPORT-Men-P12L and pCMV-SPORT-Men-L22R, were generated from pCMV-SPORT-menin (kind gift from Dr. Sunita Agarwal) using the splice overlap extension method (48) with the primers P12Lf (5 ¶-GACGCTGTTCCTGCTGCGCTC), P12Lr (5 ¶-GAGCGCAGCAGGAACAGCGTC), L22Rf (5 ¶-GGTGCGCCGGTTTGCTGCCGA), and L22Rr (5 ¶-GCAG-CAAACCGGCGCACCACG; underlined and boldfaced letter is the mutated nucleotide).
The cDNA coding for wild-type h-catenin was obtained from IMAGE clone 6151332 (Invitrogen), and the constitutively active missense mutant pCMV-SPORT-h-catenin (S37A) was a kind gift from Dr. Eric Vilain. The open reading frames of wildtype h-catenin and mutant S37A were subcloned into the mammalian expression vectors p3XF10 (Sigma-Aldrich) and pECFP-N1 (Clontech Laboratories) by PCR-TA (Invitrogen) cloning using the following primers: for p3XF10-h-catenin, HCATf 5 ¶-ggtaccATGGCTACTCAAGCTGATTTG (small case: Kpn I site) and HCATr 5 ¶-tctagaTTACAGGTCAGTAT-CAAACCA (small case: XbaI site); for pECFP-h-catenin, CATNOr 5 ¶-gatatcCCAGGTCAGTATCAAACCAGGC (small case: EcoRV site). The full-length cDNAs for TCF3 (also called TCF7L1) and TCF4 (also called TCF7L2) were purchased from Invitrogen (IMAGE clones 6141641 and 5533185, respectively) and PCR-TA cloned into plasmids p3XF10, pcDNA3.1/HisB, pEYFP-C1 (Clontech Laboratories), and pECFP-N1 using the following PCR primers: TCF3f, 5 ¶-gaattcCACCATGCCC-CAGCTCG (small case: EcoRI site); TCF3r, 5 ¶-gatatcT-TAGTGGGCAGACTTGGTG (small case: Eco RV site); TCF3Nr, 5 ¶-gatatcCGTGGGCAGACTTGGTGACC (small case: EcoRV site); TCF4f, 5 ¶-gaattcAAAAATGCCGCAGCT-GAAC (small EcoRI case site); and TCF4r, 5 ¶-gatatcTAG-TAAGCTTCCATCTGAAGA (small case: EcoRV site).
GST Pull-Down Assay
Pull-down protein interaction studies were done according to the manufacturer's recommendations (ProFound Pull-Down GST Protein:Protein Interaction Kit, Pierce Biotechnology). Briefly, the competent bacteria (BL21 strain) were transformed with either pGEX4T2 or pGEX4T2-meninD5s plasmids and grown under selective conditions to produce the ''bait'' protein.
One colony from each transformants was scraped and grown in suspension at 28jC overnight. Bacteria were diluted into fresh media the next day, and the protein expression was isopropyl-h-D-1-thiogalactopyranoside induced when the bacterial culture attained an A 600 z0.6. Induced bacteria were isolated by centrifugation and lysed in the provided buffer. GST-tagged proteins were immobilized on the glutathione-coated agarose beads according to the manufacturer's protocol. Biotinylated (Transcend Non-Radioactive Translation Detection System from Promega) full-length h-catenin, TCF3, and TCF4 proteins were made by in vitro transcription/translation reaction of pSPORT-h-catenin (construct from Invitrogen), pcDNA3.1/ HisB-TCF3, and pcDNA3.1/HisB-TCF4 following the manufacturer's recommendations (Promega, TnT Quick Coupled Transcription/Translation Systems) and added as ''prey'' to the complex of beads with immobilized GST epitope -tagged ''bait.'' The bead complexes were washed and the bound ''prey'' proteins were eluted for SDS-PAGE and further analysis by Western blot.
Transient Transfection
Culture dishes (100 mm) were seeded with either 2 
Total Cell Protein Extraction
Plated cells were washed twice in cold 1Â PBS (without calcium) buffer and then lysed in radioimmunoprecipitation assay buffer containing 50 mmol/L Tris-HCl (pH 7.4), 200 mmol/L NaCl, 1 mmol/L EDTA, 1% NP40, 0.5% sodium deoxycholate, 0.5% SDS, 2 mmol/L NaVO 4 , 2 mmol/L NaF, and 1 mmol/L phenylmethylsulfonyl fluoride supplemented with Complete Protease Inhibitor Cocktail as recommended by the manufacturer (Roche Applied Science). After a 30-min incubation on ice, the cell lysate was sonicated twice on ice (8 s), centrifuged (13,000 rpm at 4jC) for 15 min, and the supernatant was stored at À80jC for Western blotting.
Coimmunoprecipitation and Western Blot Analysis
After 48 h posttransfection, the plated cells were harvested for protein as above. The protein lysates were precleared with protein G-Sepharose 4B (Sigma-Aldrich) for 30 min and then incubated for 2 h with rat monoclonal anti-hemagglutinin or mouse monoclonal anti-HisG. Untransfected cells were treated similarly but immunoprecipitated with anti -activated h-catenin antibody (Upstate clone 8E7). Immune complexes were captured with protein G-Sepharose 4B beads for an additional hour, centrifuged, washed four times in radioimmunoprecipitation assay buffer, and then solubilized in SDS sample buffer. Proteins were analyzed on precast 4% to 12% gel (Invitrogen) and immunoblotted with mouse monoclonal anti-FLAG antibody. The immune complexes were detected by horseradish-conjugated secondary antibody and developed by enhanced chemiluminescence (Amersham Pharmacia Biotech). Images were digitized with Quantity One Software (Bio-Rad) using the Bio-Rad Versadoc Imaging System Model 3000. The images were prepared for publication with Adobe Photoshop and Illustrator software.
Luciferase Assays
All luciferase assay experiments were done in triplicate, with data reported as mean F SD. Twenty-four-well plates were seeded with 3 Â 10 4 TGP-61 cells 24 h before transfection. Cells were transfected with different plasmids (including M50, M51, and pRL-hTK) using Effectene Transfection Reagent. An equal amount of transfected plasmid DNA was ensured between different samples in each experimental group by adding empty control vector plasmid DNA as needed. Twenty-four hours after transfection, the medium was changed to fresh medium containing 5% charcoal stripped serum. Twenty-four hours later, the cells were lysed in 1Â PLB, and luciferase assays were done using the Dual-Luciferase Reporter Assay System as recommended by the manufacturer (Promega). SDS-PAGE sample buffer was added to the remaining lysate, and Western blotting was done to ensure every transfected plasmid was expressed for each samples.
Chromatin Immunoprecipitation Assay
The chromatin immunoprecipitation assays were done following the protocol described with some minor modifications (49) . Briefly, after different transfections and treatments, 37% formaldehyde (Fisher Scientific) was added directly to culture medium in the plate to a final concentration of 1% to cross-link the proteins to the DNA. After incubation for 10 min at 37jC, cells were washed twice using ice-cold PBS containing protease inhibitor cocktail. Cells were scrapped from the plate and harvested into 1.5-mL Eppendorf tubes and then briefly centrifuged. Cell pellets were lysed in 800-AL SDS lysis buffer containing 1% SDS, 10 mmol/L EDTA, and 50 mmol/L Tris-HCl (pH 8.1) with freshly added protease inhibitor cocktail. After a 10-min incubation on ice, the lysates were sonicated thrice for 10 s on ice and centrifuged. Then the supernatant (200 AL) was diluted with 1,800 AL of chromatin immunoprecipitation dilution buffer containing 0.01% SDS, 1.1% Triton X-100, 1.2 mmol/L EDTA, 16.7 mmol/L Tris-HCl (pH 8.1), and 167 mmol/L NaCl, with freshly added protease inhibitor cocktail. An aliquot of diluted sample (200 AL) was saved as input control DNA and, after adding 8 AL of 5 mol/L NaCl, reverse cross-linked at 65jC overnight. The remaining samples were precleared with 50 AL of salmon sperm DNA/ protein G-Sepharose-50% slurry for at least 30 min at 4jC with agitation. The supernatant fractions were collected and either anti -trimethyl-H3K4 (Upstate USA, Inc.) or anti-menin antibody was added for immunoprecipitation with rotation at 4jC overnight followed by adding 50 AL of salmon sperm DNA/protein G-Sepharose slurry for 1 h at 4jC with rotation to collect the immunocomplex. For a negative control, a noantibody immunoprecipitation was done by incubating the supernatant fraction with 50 AL of salmon sperm DNA/protein G-Sepharose slurry for 1 h at 4jC before washing the beads. The samples were washed and eluted, and the DNA was extracted with a commercial DNA extraction kit (Qiagen). The DNA was eluted in 30 AL Tris (pH 8.5) buffer, PCR amplified with AccuPrime Taq polymerase (Invitrogen), and analyzed by electrophoresis on agarose gel. The primers used to amplify the mouse Axin2 promoter region, designated as T2/3, were mt23F, 5 ¶-G C G G C G G G AT C A C T G G C T, a n d m t 2 3 R , 5 ¶-TCCTCCGGGCGCTTCCAAC (36).
RT-PCR
HEK 293T cells and TGP-61 cells were plated in a six-well plate 24 h before transfection. Cells were transfected with different expression plasmids using Effectene Transfection Reagent. Two days later, the total RNA was extracted with Trizol (Invitrogen). The first cDNA was synthesized using the 1st cDNA Synthesis Kit (GE Healthcare Lifesciences), and followed by RT-PCR with Taq DNA polymerase (Invitrogen). 
Microscopy Analysis
Forty-eight hours after transfection with fluorescent protein expression constructs, TGP-61 cells grown on coverslips were washed twice with cold PBS (Sigma) and fixed with 0.5% paraformaldehyde for 30 min. Fixed cells were washed twice more with cold PBS and incubated with 1 ng/mL bisbenzimide H 33258 (Sigma). Coverslips were mounted on slides using Vectashield (Vector Labs) and viewed under a microscope (Leica DMIL) with appropriate band-pass filters (Chroma) for ECFP, EYFP, and Hoechst stain using a 63Â objective. Images were captured with a Hamamatsu Orca II cooled charge-coupled device camera and data were analyzed with Metamorph (Molecular Devices) software to create merged images. The final images were assembled in Adobe Photoshop and Illustrator software to create the publication images.
Cell Counting
All cell counting experiments were done in triplicate, with data reported as mean F SD. TGP61 cells (2.4 Â 10 5 ) were plated on six-well plates. The following day, the medium was changed to fresh medium containing 5% charcoal-stripped serum. One set of cells were trypsinized and counted on a hemacytometer, and the remaining cells were treated with vehicle (DMSO) or 5 Amol/L GSK3h inhibitor for 1, 2, and 3 d. Each day, the medium was changed with fresh medium containing 5% charcoal-stripped serum and treatment was continued with GSK3h inhibitor.
Flow Cytometry
Adherent cells were detached and collected with 0.25% trypsin (Sigma). Cells were pelleted by centrifugation and resuspended in propidium iodide staining buffer (sodium citrate 250 mg, 0.75 mL Triton X-100, propidium iodide 25 mg, RNase A 5 mg, and distilled H 2 O to final volume of 250 mL) and stored in the dark at 4jC until flow cytometry (<1 h). Cells were then passed through a FACScan cytometer (BectonDickinson) controlled with CellQuest software and the data were analyzed with the ModFit software.
Statistical Analysis
Microsoft Excel software was used for data management (calculating mean and SD) and creating graphs. All luciferase assays were done with triplicate plasmid transfections, with data presented as mean F SD.
